5941 - 5950 of 8761 Results
Title
Year
- Effect of dopaminergic medications on Montreal Cognitive Assessment in Parkinson's disease patients2025RESTRICTEDTitle: Effect of dopaminergic medications on Montreal Cognitive Assessment in Parkinson's disease patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 138Issue #:Start Page: 107951End Page: 107951Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107951Citation Count: 0
- Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial2025OPENTitle: Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized TrialJournal Name: Movement DisordersPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70028Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70028Citation Count: 0
-
OPENTitle: CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative studyJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 131Issue #: 6Start Page: 935End Page: 949Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-016-1552-2Best OA location URL: http://doi.org/10.1007/s00401-016-1552-2Citation Count: 199
-
RESTRICTEDTitle: Allosteric modulation of mGluR4 as a novel therapeutic direction for the treatment of Parkinson's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 22Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fasebj.22.1_supplement.103.2Citation Count: 0
-
OPENTitle: Aplp1 interacts with Lag3 to facilitate transmission of pathologic α-synucleinJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-49016-3Best OA location URL: https://doi.org/10.1038/s41467-024-49016-3Citation Count: 12
-
OPENTitle: Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 100Issue #:Start Page: 119.e7End Page: 119.e13Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.10.019Best OA location URL: https://hal.umontpellier.fr/hal-03226126Citation Count: 30
-
OPENTitle: shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and ToxicityJournal Name: PLOS GeneticsPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 4Start Page: e1005995End Page: e1005995Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pgen.1005995Best OA location URL: https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1005995&type=printableCitation Count: 80
-
OPENTitle: Genome‐Wide Analysis of Structural Variants in Parkinson DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 93Issue #: 5Start Page: 1012End Page: 1022Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.26608Best OA location URL: https://pub.dzne.de/record/255487Citation Count: 26
-
RESTRICTEDTitle: Advantages of timing the duration of a freezing of gait-provoking test in individuals with Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 267Issue #: 9Start Page: 2582End Page: 2588Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-020-09856-7Citation Count: 9
-
OPENTitle: Alterations of Brain Signal Oscillations in Older Individuals with HIV Infection and Parkinson’s DiseaseJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 16Issue #: 2Start Page: 289End Page: 305Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11481-020-09914-xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7554056Citation Count: 6